The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing

Community Acquired Pneumonia Clinical Trial

Official title:

The Establishment and Improvement of Community Acquired Pneumonia Monitoring and Disposal Network in Beijing

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01236677
• Other study ID #: xfcrb123456
• Status: Recruiting
• Phase: N/A
• First received: November 8, 2010
• Last updated: December 13, 2010
• Start date: August 2010
• Est. completion date: December 2011

Study information

• Verified date: August 2010
• Source: Capital Medical University
• Contact: Bin Cao, Doctor
• Phone: 86-010-85231167
• Email: caobin1999[@]gmail.com
• Is FDA regulated: No
• Health authority: China: Beijing Municipal Science and Technology Commission
• Study type: Observational

Clinical Trial Summary

In the 21st century, threats to human health of new respiratory infectious diseases increased.

The project aim is to establish pneumonia pathogens network in Beijing and understand the pathogen spectrum distribution.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1100
• Est. completion date: December 2011
• Est. primary completion date: December 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 14 Years to 90 Years

Eligibility

Inclusion Criteria:

1. Confirmed community acquired pneumonia

2. Age=14 ys

3. New appear of cough or cough become severe

4. New infiltration showed by chest radiology(x-ray or CT)

5. Fever T>37.8o C or <35.6o C

6. White blood cell>10,000/mm3 , left shift or leukopenia<4000/ul)

Exclusion Criteria:

1. Pregnancy or breast-feeding

2. Over one week after the onset of symptoms

3. HIV infection

4. Recent 90-day hospitalized history(length of stay greater than 2 days)

5. Live in nursing homes or rehabilitation hospitals

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Community Acquired Pneumonia
• Pneumonia

Locations

Country	Name	City	State
China	Capital Medical University affiliated Beijing Chaoyang Hospital, Beijing Respiratory Medicine Insititute	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Capital Medical University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Time to resolution of all symptoms (defined as the period from start of study-drug to relief of fever)		one year	No
Secondary	If duration of symptoms long, follow-up 30 days.		one year	No
Secondary	In case of early termination:death;diagnosed tuberculosis;diagnosed lung cancer and HIV infection		one year	No